Université Paris-Saclay, INRAE, UVSQ, VIM, 78350, Jouy-en-Josas, France.
Aix-Marseille University, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Turing Center for Living Systems, Marseille, France.
Front Immunol. 2023 Jul 3;14:1142228. doi: 10.3389/fimmu.2023.1142228. eCollection 2023.
In response to the increasing demand for lung transplantation, lung perfusion (EVLP) has extended the number of suitable donor lungs by rehabilitating marginal organs. However despite an expanding use in clinical practice, the responses of the different lung cell types to EVLP are not known. In order to advance our mechanistic understanding and establish a refine tool for improvement of EVLP, we conducted a pioneer study involving single cell RNA-seq on human lungs declined for transplantation. Functional enrichment analyses were performed upon integration of data sets generated at 4 h (clinical duration) and 10 h (prolonged duration) from two human lungs processed to EVLP. Pathways related to inflammation were predicted activated in epithelial and blood endothelial cells, in monocyte-derived macrophages and temporally at 4 h in alveolar macrophages. Pathways related to cytoskeleton signaling/organization were predicted reduced in most cell types mainly at 10 h. We identified a division of labor between cell types for the selected expression of cytokine and chemokine genes that varied according to time. Immune cells including CD4 and CD8 T cells, NK cells, mast cells and conventional dendritic cells displayed gene expression patterns indicating blunted activation, already at 4 h in several instances and further more at 10 h. Therefore despite inducing inflammatory responses, EVLP appears to dampen the activation of major lung immune cell types, what may be beneficial to the outcome of transplantation. Our results also support that therapeutics approaches aiming at reducing inflammation upon EVLP should target both the alveolar and vascular compartments.
为了满足对肺移植的需求不断增加,肺灌注(EVLP)通过修复边缘供体肺,扩大了合适供体肺的数量。然而,尽管在临床实践中得到了广泛应用,但不同的肺细胞类型对 EVLP 的反应尚不清楚。为了深入了解其机制,并建立改进 EVLP 的精细工具,我们进行了一项先驱性研究,对因移植而衰竭的人类肺进行了单细胞 RNA-seq。对在 EVLP 处理的两个人类肺中,在 4 小时(临床持续时间)和 10 小时(延长时间)生成的数据集进行整合后,进行了功能富集分析。预测上皮细胞和血管内皮细胞、单核细胞衍生的巨噬细胞以及在 4 小时时的肺泡巨噬细胞中的炎症相关途径被激活。在大多数细胞类型中,与细胞骨架信号/组织相关的途径在 10 小时时被预测减少。我们发现细胞类型之间存在分工,用于选择表达细胞因子和趋化因子基因,其表达模式根据时间而变化。免疫细胞包括 CD4 和 CD8 T 细胞、NK 细胞、肥大细胞和常规树突状细胞,其基因表达模式表明在几个实例中,4 小时时已经存在激活减弱,在 10 小时时进一步减弱。因此,尽管 EVLP 会引发炎症反应,但它似乎会抑制主要肺免疫细胞类型的激活,这可能有利于移植的结果。我们的研究结果还表明,旨在减少 EVLP 时炎症的治疗方法应该针对肺泡和血管两个部分。